COMMON SHARES PURCHASE WARRANT ALGERNON PHARMACEUTICALS INC.Common Shares Purchase • June 3rd, 2022 • Algernon Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS COMMON SHARES PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on ________1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Algernon Pharmaceuticals Inc., a company existing under the laws of the Province of British Columbia, Canada (the "Company"), up to ______ Common Shares (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder
SOPHIRIS BIO INC. OMNIBUS AMENDMENT TO COMMON SHARES PURCHASE WARRANTSCommon Shares Purchase • February 6th, 2014 • Sophiris Bio Inc. • Pharmaceutical preparations • British Columbia
THIS OMNIBUS AMENDMENT TO COMMON SHARES PURCHASE WARRANTS (this “Agreement”) is made as of January 31, 2014, by and among SOPHIRIS BIO INC., an organization incorporated under the Company Act of British Columbia, f/k/a Protox Therapeutics Inc. (the “Company”), and WARBURG PINCUS PRIVATE EQUITY X, L.P. and WARBURG PINCUS X PARTNERS, L.P., each a Delaware limited partnership (each a “Holder” and together the “Holders”), to amend those certain Common Shares Purchase Warrants (each a “Warrant” and collectively the “Warrants”) set forth in ATTACHMENT 1 attached hereto. Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Warrants.
